Is NCT07098338 recruiting in Fairfax, VA?

Yes, NCT07098338 is currently recruiting participants at its Fairfax, VA location. This non-small cell lung cancer clinical trial is actively enrolling qualified participants.

How do I join the non-small cell lung cancer clinical trial in Fairfax?

To join this clinical trial in Fairfax, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Fairfax clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Fairfax, VANCT07098338Now EnrollingIRB Ready

Non-Small Cell Lung Cancer Clinical Trial in Fairfax, VA

Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Fairfax. Study-provided care at no cost to qualified participants.

Expert Care in Fairfax

Access non-small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer treatment provided free

Apply for This Fairfax Location

Check if you qualify for this non-small cell lung cancer clinical trial in Fairfax, VA

Why Participate?

No-Cost Study Care
Local to Fairfax
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

1Submit this form
2Phone screening
3Visit Fairfax site if eligible
4Begin participation

About This Non-Small Cell Lung Cancer Study in Fairfax

This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or metastatic NSCLC. The study will consist of several sub-studies, each evaluating the safety, tolerability, and preliminary antitumour activity of various treatment combinations. This study will be conducted in approximately 80 centers globally across 10 countries.

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

for All Sub-studies:

Participant must be ≥ 18 years of age at the time of signing the ICF

WHO/ECOG performance status of 0 or 1

At least 1 lesion that qualifies as a RECIST 1.1 Target Lesion (TL) at baseline.

Adequate bone marrow and organ function

Life expectancy ≥ 12 weeks

Provision of acceptable tumour tissue Specific Inclusion Criteria for Sub-Study 1 and Sub-Study 2:

Histologically or cytologically documented advanced or metastatic NSCLC

PD-L1 TC ≥ 1% (TC≥ 50% for sub-study 1, 1-49% for sub-study 2)

Absence of sensitizing EGFR mutations or ALK rearrangements. No known other Actionable Genomic Alterations(AGAs) Specific Inclusion Criteria for Sub-Study 3:

Histologically or cytologically documented advanced or metastatic non-squamous NSCLC

Documented positive AGA and had progressed on prior targeted therapy

Exclusion Criteria

for All Sub-studies:

As judged by the investigator, any severe or uncontrolled systemic diseases, in the inve

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fairfax?

Yes, this clinical trial (NCT07098338) has an active research site in Fairfax, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Small Cell Lung Cancer Treatment Options in Fairfax, VA

If you're searching for non-small cell lung cancer treatment options in Fairfax, VA, this clinical trial (NCT07098338) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fairfax research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Fairfax, VA

See all lung cancer clinical trials recruiting in Fairfax — not just this study.

Browse Lung Cancer Trials in Fairfax →

Browse More Trials by Condition

Lung Cancer Trials Leukemia Trials Small Cell Lung Cancer Trials Non-Small Cell Lung Cancer Trials Spinal Muscular Atrophy Trials All Conditions →

Ready to Join in Fairfax?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fairfax, VA